GLP-1 Injection: ভারতে Weekly Pen নিরাপদ ব্যবহার
Weekly injection pen majority Indian patient semaglutide, dulaglutide, tirzepatide other GLP-1 RA take। correct technique comfort, site reaction, potency protect—refrigeration/sharps disposal plan দরকার home-এ।
Short answer
GLP-1 RA injection সাধারণত weekly abdomen/thigh/upper arm subcutaneous pre-filled pen। first use-এর আগে refrigerate, hand hygiene, site rotation, local rule sharps disposal। doctor titration schedule ও label follow। Kesho educate only—individual device training prescribe/demonstrate নয়।
Key takeaways
- •Weekly GLP-1 RA pens are injected subcutaneously—not into muscle or vein—with technique taught by your doctor or pharmacist.
- •Cold-chain storage (2°C–8°C) before first use is critical; after opening, most pens tolerate room temperature below 30°C for several weeks.
- •Rotate injection sites weekly to reduce skin reactions and lipodystrophy.
- •Never share pens, reuse needles, or use expired or improperly stored devices.
- •Schedule injections on the same day each week and set reminders during dose titration phases.
Before your first injection
Your first GLP-1 receptor agonist injection should ideally occur after hands-on training from your doctor, nurse, or pharmacist. Different pen devices—used across the semaglutide, dulaglutide, liraglutide, and tirzepatide drug class—have slightly different button mechanisms, dose windows, and priming steps. Read the patient information leaflet in your CDSCO-approved packaging even if you have watched online videos; device designs change between manufacturers. Confirm your prescription strength matches the pen label (for example, 0.25 mg titration dose versus 0.5 mg or 1 mg maintenance). Set a recurring weekly reminder on the same day and time—consistency supports steady drug levels and helps you notice side-effect patterns. Keep a simple log: date, site used, dose, and any nausea or injection-site reaction. Bring this log to follow-up visits during titration.
- Subcutaneous injection
- An injection into the fatty tissue just beneath the skin—not into muscle or a blood vessel—used for most GLP-1 receptor agonist pens.
Storage and cold-chain rules in Indian homes
Injectable GLP-1 RAs require refrigeration between 2°C and 8°C before first use. Store pens in the main refrigerator compartment—not the freezer door where temperatures fluctuate. During summer load-shedding or travel, use insulated bags with ice packs validated for medicine transport; avoid leaving pens in a hot car. After first use, most weekly pens may be kept at room temperature below 30°C for a defined period per manufacturer label—often four to six weeks. Protect from direct sunlight and heat. Never freeze a pen; discard if frozen. Oral semaglutide tablets follow different storage rules and are not covered in this injection guide. When purchasing from a pharmacy, confirm the pen arrived cold; room-temperature shipped injectables from unverified sellers are a safety concern.
Preparing the pen
Wash hands with soap and water. Remove the pen from the refrigerator and let it sit at room temperature for 15–30 minutes if cold injections cause discomfort—check your specific product leaflet. Inspect the pen: clear colourless to slightly yellow solution without particles or cloudiness. Attach a new sterile needle if your device requires separate needles; some pens come with built-in hidden needles. Prime the pen if instructed—this expels air and ensures full dose delivery. Select an injection site: abdomen at least five centimetres from the navel, front of thigh, or back of upper arm (may need assistance). Avoid scars, moles, bruises, or areas of lipodystrophy from repeated injections at the same spot.
Injection technique step by step
Clean the site with an alcohol swab if available and let dry. Pinch a fold of skin gently. Insert the needle at a 90-degree angle for most patients; very lean individuals may use 45 degrees per training. Press the injection button fully and hold per device instructions—often five to ten seconds—to deliver the complete dose. Withdraw the needle and release the skin pinch. Do not rub the site aggressively; light pressure with a cotton swab is sufficient. Immediately dispose of the needle in a sharps container. Never recap needles by hand. If blood appears, apply gentle pressure—this is usually harmless. If you are unsure the full dose was delivered, do not repeat the injection without medical advice; contact your care team. For upper-arm injections, ask a family member for assistance to ensure proper angle and visibility.
Site rotation and skin care
Rotate injection sites each week: if you used the right abdomen last week, choose left thigh or alternate abdomen quadrant this week. Rotation reduces lipodystrophy—fatty lumps under the skin that can affect absorption—and minimises local itching or redness. Mild injection-site reactions are uncommon with weekly GLP-1 pens but possible. Persistent nodules, severe pain, or signs of infection require medical review. Avoid injecting through clothing. Loose comfortable clothing helps after abdominal injections, especially for patients who wear sarees or tight waistbands. Moisturise skin generally but not immediately on the injection site before needling.
Pair your weekly injection with a recurring phone alarm labelled with dose strength during titration. Note any nausea in the next 24–48 hours to discuss at follow-up.
Understanding dose titration schedules
GLP-1 receptor agonists are started at low doses and increased every four weeks or per your physician's plan. Semaglutide weekly injection commonly begins at 0.25 mg for four weeks, then 0.5 mg, with further increases to 1 mg or 2 mg depending on indication and tolerance. Tirzepatide and dulaglutide follow their own labelled titration pathways. Do not skip ahead to higher doses because of impatience—rapid escalation increases nausea risk without improving long-term outcomes. If you miss a weekly dose within a defined window, product labels specify whether to take promptly or wait until the next scheduled day; do not double doses. Oral semaglutide uses daily titration and is a separate regimen. Your diabetologist adjusts the schedule based on HbA1c, weight response, and side effects.
Common mistakes to avoid
Sharing pens between family members—even if both have diabetes—is unsafe due to infection risk and wrong dosing. Reusing needles blunts tips, increases pain, and raises infection risk. Injecting intramuscularly by mistake may alter absorption. Using expired pens or pens left unrefrigerated for extended periods compromises potency. Buying pens without prescription from social-media sellers bypasses cold-chain assurance. Stopping injections abruptly without medical guidance may cause glycaemic rebound. If injection phobia is a barrier, discuss oral semaglutide or counselling with your doctor—never abandon therapy silently.
When to contact your care team after injection
Contact your doctor the same day for spreading warmth, pus, fever, or severe pain suggesting infection. Report persistent nausea preventing fluids for more than twenty-four hours, especially during heat waves. Sudden allergic symptoms—lip swelling, breathing difficulty, widespread rash—require emergency care. If you suspect a partial dose or device malfunction, document the pen counter reading and call your clinic rather than guessing a supplemental dose. Transplant recipients, pregnant patients planning therapy cessation, and elderly frail individuals should have lower thresholds for early contact. Caregivers administering upper-arm injections should be trained to recognise these warning signs when patients feel unwell after self-injecting.
First-month confidence building
Injection anxiety is normal among Indian patients new to self-injectable therapy. Practise pen handling with cap on before first dose. Inject at the same time weekly—Sunday morning before breakfast works for many families. Pair injection with a habit you already have: after brushing teeth, before Sunday video call with parents. If blood appears at the site, apply gentle pressure with cotton; small bleeds are common and not dangerous. Bruises fade with site rotation. Confidence grows by week three for most patients. If phobia persists, oral semaglutide or nurse-administered clinic injections may be alternatives—discuss with your doctor rather than skipping doses silently.
Generic pen device differences
CDSCO-approved generic semaglutide pens may use different click mechanisms, dose counters, or needle attachment systems than innovator devices you saw in tutorials. When your pharmacy switches manufacturers after hospital tender changes, ask for a sixty-second device demonstration at the counter. Never assume identical technique across brands. Keep patient leaflets for each manufacturer in your medicine folder. Device confusion is a common cause of partial dosing and perceived treatment failure in the first month after generic switches.
Rotating sites over months of therapy
Maintain a simple paper diagram marking abdomen quadrants and thighs used each week. Reusing same two-centimetre zone causes lipohypertrophy and erratic absorption. After six months many patients forget rotation discipline—review technique at follow-up. Scar tissue from old sites feels lumpy; move to fresh area and mention at next visit.
Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 26, 2026